Metraipolis › archive › dc_e449ecfa8389
Engineering Strategies for Allogeneic T Cell-Based Platforms in Cancer Immunotherapy — Europe PMC PMID:42515674
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42515674
- DOI
- 10.3390/ph19070991
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T19:51:16.600Z
- SHA-256 of the archived text
cb9dd44011406fef141e84112cc6d735f2fa05aa0023390a354d8a8e96327f4c- Stable URL of this page
https://metraipolis.com/documento/dc_e449ecfa8389
How to cite
Engineering Strategies for Allogeneic T Cell-Based Platforms in Cancer Immunotherapy — Europe PMC PMID:42515674 — Europe PMC (en), https://europepmc.org/article/MED/42515674 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e449ecfa8389 (Metraipolis archive dc_e449ecfa8389, sha256 cb9dd44011406fef141e84112cc6d735f2fa05aa0023390a354d8a8e96327f4c)
BibTeX
@misc{dce449ecfa8389,
title = {Engineering Strategies for Allogeneic T Cell-Based Platforms in Cancer Immunotherapy — Europe PMC PMID:42515674},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42515674},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e449ecfa8389; sha256 cb9dd44011406fef141e84112cc6d735f2fa05aa0023390a354d8a8e96327f4c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42515674. Agents can read the archived copy with the MCP tool read_document.